Alzheimer's Treatment
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT05551741
A First in Human Study of IBC-Ab002 in Persons With Early Alzheimer's Disease (AD)
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 23, 2023
Completion: Nov 1, 2025
Loading map...